About Attovia Therapeutics Inc
Attovia™ is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need.
Attovia Therapeutics Inc (ATTO) Stock Score & Signals
Attovia Therapeutics Inc (ATTO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 26 out of 100.
2BB score and signals
Attovia Therapeutics Inc’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 16 | Very Low |
| Momentum | 32 | Weakening |
| Financial strength | 19 | Very Weak |
| Quality | 60 | Strong |
| Risk | 82 | Very High (provisional) |
Company facts
| Headquarters | San Carlos, California, United States |
| Founded | 2022 |
| Employees | 44 |
| 52-week range | $14.23 – $28.00 |